Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Anal Canal Carcinoma × Taxes × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 77 Stomach Neoplasms 16 Esophageal Neoplasms 13 Carcinoma, Non-Small-Cell Lung 10 Neoplasms 9 Cholangiocarcinoma 9 Breast Neoplasms 8 Colorectal Neoplasms 7 Adenocarcinoma Of Esophagus 7 Ovarian Neoplasms 6 Neoplasm Metastasis 6 Endometrial Neoplasms 6 Carcinoma, Ovarian Epithelial 6 Prostatic Neoplasms 5 Pancreatic Adenocarcinoma 5 Lung Neoplasms 5 Gallbladder Neoplasms 5 Esophageal Squamous Cell Carcinoma 5 Squamous Cell Carcinoma of Head and Neck 4 Biliary Tract Neoplasms 4 Adenocarcinoma 4 Urinary Bladder Neoplasms 3 Sarcoma 3 Melanoma 3 Liver Neoplasms 3 Colonic Neoplasms 3 Carcinoma, Renal Cell 3 Advanced Pancreatic Cancer 3 Uterine Cervical Neoplasms 2 Small Cell Lung Carcinoma 2

Interventions

Fluorouracil 8 Cisplatin 7 Radiotherapy 6 Magnetic Resonance Spectroscopy 4 Specimen Handling 3 Radiotherapy, Intensity-Modulated 3 Mitomycin 3 Capecitabine 3 dehydroftorafur 2 Radiation 2 Nivolumab 2 Cetuximab 2 Biopsy 2 toripalimab 1 pembrolizumab 1 atezolizumab 1 X-Rays 1 Watchful Waiting 1 Vaccines 1 Taxes 1 Sigmoidoscopy 1 Radiosurgery 1 Proctoscopy 1 Platinum 1 Phantoms, Imaging 1 Paclitaxel 1 Observation 1 Neoadjuvant Therapy 1 Mitozytrex 1 Mitomycins 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02560298 2023-06-22

InterAACT

Eastern Cooperative Oncology Group

Phase 2 Unknown

Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡